← Back to news
Y

Yahoo Finance

L1 Capital International Trimmed HCA Healthcare (HCA) on Valuation Consideration

Y

Buy, Sell or Hold TSM Stock Below $500 or NVDA Stock Below $200?

Y

Snap Was Always A Terrible Company

Y

PepsiCo Q1 2026 earnings beat as snack price cuts lift volumes

Y

Here's What to Expect From TransDigm Group's Next Earnings Report

Y

Schwab (SCHW) Q1 2026 Earnings Call Transcript

Y

WESPAC Advisors Buys $5.71 Million Stake in JPMorgan International Value ETF

Y

Goldman Sachs Raises Dell Price Target to $215: Is This AI Server Powerhouse Still the Best Value in Tech?

Y

Morgan Stanley Gets Dual Price Target Hikes From Barclays and Goldman Sachs: Is Wall Street’s Wealth King a Must-Own?

Y

Tesla Could Start Making the Optimus Robot at Its Gigafactory Shanghai. What Does That Mean for TSLA Stock?

Y

CoStar Group (CSGP) is Among the Best Low-Risk High-Reward Stocks

Y

Is Compass (COMP) One of the Best Low-Risk High-Reward Stocks?

Y

Citi Trims PT on Guidewire Software (GWRE) to $137 Amid Valuation Concerns in Software Sector

Y

Zillow Group (Z)’s New Zillow Preview Feature Set to Expand Reach of Pre-Market Listings

Y

Builders FirstSource (BLDR) Trading Near 52-Week Low; Yet Analysts See 45% Upside

Y

Analysts See 65% Upside for Intuit (INTU) Despite 40% One-Year Share Price Decline

Y

Analysts Bullish on Boston Scientific (BSX) Amid Expectations for 30% YoY Growth in 2026

Y

Is Nike’s dividend safe? Yield & payout ratio explained

Y

J.B. Hunt says TL inflection ‘structural,’ not temporary

Y

Snatch This Swing Trade Opportunity as Sugar Surplus Concerns Sink Prices

Y

As Alibaba Enters the Robot Race, Should You Buy, Sell, or Hold BABA Stock?

Y

Charles Schwab To Launch Bitcoin And Ethereum Trading

Y

Dollar Gains on Solid US Economic News and Hawkish Wiliams

Y

AI Agents Could Be a Boon, Not a Replacement, for Okta. An Analyst Says Buy Now.

Y

Is This Beaten-Down Financial Stock Finally Worth Buying?

Y

How to get a low interest loan in 7 steps

Y

BofA Raises Hims & Hers Target to $25 as FDA Takes a Step Toward Wellness Peptides: Is a New Revenue Boom Coming?

Y

A trader made $1.5m buying Anthropic ‘shares’ on Solana. Cashing out the win won’t be easy

Y

As Nvidia Sparks a Rally in IONQ Stock, Is the Quantum Computing Company a Buy, Sell, or Hold?

Y

What is an unsecured loan?

Y

Outlook for Canada Existing-Home Sales Deteriorates on War-Fueled Jump in Rates

Y

SpotOn and Popmenu collaborate to help restaurants streamline operations

Y

JPMorgan Downgrades Qualcomm and Puts It on Negative Watch: Is the Smartphone Giant’s Best Days Behind It?

Y

Jensen Huang Says Nvidia Turns Electrons Into Tokens. That’s the Whole Business.

Y

Pros and cons of debt consolidation: Is it a good idea?

Y

BMO Raises Snap’s Target After 1,000-Job Cut: Is the Restructuring Finally the Catalyst Bulls Have Been Waiting For?

Y

When to use a personal loan to pay off credit card debt

Y

Bank of England says it is testing AI risks to financial system

Y

Fidelity National Earnings Preview: What to Expect

Y

SNS Financial Sells $5.88 Million of BulletShares 2026 Ahead of December Closure

Y

Should you get a personal loan? Here are the pros and cons

Y

Citi Trims DraftKings’ Target to $29 Ahead of Q1: Is the Sports Betting Boom Losing Momentum?

Y

JB Hunt Stock Breaks Out After First Sales Gain Since 2022

Y

How Andy Jassy Just Convinced Me That Amazon Stock Is a Buy

Y

Travelers Earnings Beat Estimates. Why the Stock Is Dropping Despite a Dividend Increase.

Y

EQT’s $11 Billion Buyout Bid Rejected by U.K. Testing Specialist Intertek

Y

Stocks Pressured by Weakness in Chipmakers

Y

Raymond James Upgrades Okta to Outperform: Is This Beaten-Down Cybersecurity Stock a Screaming Buy at $60?

Y

How Should You Trade Marvell Technology Stock at New Record Highs?

Y

China Expected To Launch Yuan Stablecoin Within Five Years

Y